Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Overexpression Of A Disintegrin And Metalloproteinase 9 (adam9) In Relation To Poor Prognosis Of Patients With Oral Squamous Cell Carcinoma.
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Overexpression Of A Disintegrin And Metalloproteinase 9 (adam9) In Relation To Poor Prognosis Of Patients With Oral Squamous Cell Carcinoma.

Related Experiment Video

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

383

Overexpression of a disintegrin and metalloproteinase 9 (ADAM9) in relation to poor prognosis of patients with oral squamous cell carcinoma.

Shuangjiang Wu1,2,3, Lang Cheng4, Tao Luo5

  • 1Department of Oral and Maxillofacial Surgery, The Affiliated Hospital, Southwest Medical University, Luzhou, China.

Discover Oncology
|October 23, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

This study examines ADAM9, CDCP1, and tissue plasminogen activator (t-PA) in oral squamous cell carcinoma (OSCC). Findings reveal their expression patterns and impact on patient survival, offering new insights into OSCC progression.

Keywords:
A disintegrin and metalloproteinase 9CUB domain-containing protein 1Oral squamous cell carcinomaOverexpression

More Related Videos

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.5K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K

Related Experiment Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

383
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.5K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • ADAM9 and tissue plasminogen activator (t-PA) are implicated in oral squamous cell carcinoma (OSCC) progression.
  • The role of CDCP1 in OSCC remains largely uncharacterized.
  • Concurrent expression of these molecules in OSCC and their prognostic significance are not well-established.

Purpose of the Study:

  • To evaluate the expression levels of ADAM9, CDCP1, and t-PA in OSCC tissues compared to normal oral tissues.
  • To investigate the correlation between the expression of these biomolecules and the clinicopathological features of OSCC.
  • To determine the impact of ADAM9, CDCP1, and t-PA expression on the survival outcomes of OSCC patients.

Main Methods:

  • Quantitative analysis of ADAM9, CDCP1, and t-PA expression in OSCC and normal oral tissue specimens.
Tissue-type plasminogen activato
  • Statistical analysis to correlate biomarker expression with clinicopathological parameters (e.g., tumor stage, lymph node metastasis).
  • Survival analysis (e.g., Kaplan-Meier curves) to assess the prognostic value of the investigated biomarkers.

    • Main Results:

    • Differential expression patterns of ADAM9, CDCP1, and t-PA were observed between OSCC and normal tissues.
    • Specific expression levels of these molecules were found to correlate significantly with certain clinicopathological features.
    • The combined or individual expression of ADAM9, CDCP1, and t-PA showed a significant association with patient prognosis.

    Conclusions:

    • ADAM9, CDCP1, and t-PA are potential diagnostic and prognostic biomarkers in OSCC.
    • Understanding their concerted roles may elucidate mechanisms of OSCC metastasis and progression.
    • Targeting these molecules could offer novel therapeutic strategies for improving OSCC patient outcomes.